• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Piramed

edit

Piramed Limited, a biotech company, discovers and develops new medicines for the treatment of cancer and immune inflammatory disorders. The company focuses on the discovery and development of inhibitors to find clinical utility in various diseases, including cancer, immune inflammatory disorders, cardiovascular disease, and pain, as well as metabolic and infectious diseases. The company was incorporated in 2001 and is based in Slough, the United Kingdom. As of May 23, 2008, Piramed Limited operates as a subsidiary of Hoffmann-La Roche Inc.

Recent Milestones

edit

• 
  Piramed was acquired by Hoffmann-La Roche for $175M. (4/15/08)
  Posted 9/21/09 at 5:51am via roche.com
• 
  Piramed added Michael Moore as CEO.
  Posted 9/21/09 at 5:49am
• 
  Piramed added Michael D. Waterfield as Co-founder .
  Posted 9/21/09 at 5:49am

Videos

Screenshots

edit

Sources

1. Roche fully acquires privately-owned biotech company Piramed (roche.com) [edit]